Avita Medical Ltd (RCEL)

[inversor86]

A Little Insider Buying!

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=93781


It was an indirect purchase but I'll take that. As usual it did nothing for the share price because nobody is watching this stock. 150 shares traded today. I added 350 shares to my IRA a couple weeks ago. I still think the $8 price target is very realistic.

Copy and paste below.

Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Avita Medical Limited
ABN 28 058 466 523
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director Ian Keith Macpherson
Date of last notice 22 October 2012
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Shares held by Fats Pty Ltd and Macadam Pty
Ltd of which Mr Macpherson is a Director
and shareholder
Date of change 30 October 2012
No. of securities held prior to change Indirect 10,399,997 shares
Class Ordinary Fully Paid Shares
Number acquired 400,000
Number disposed -
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$0.12 per share
No. of securities held after change Indirect 10,799,997 Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Off-Market – Placement as approved by
shareholders at 19 October 2012 shareholder
meeting
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change
Part 3 –
+Closed period
Were the interests in the securities or contracts detailed
above traded during a
+
closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
NA
If prior written clearance was provided, on what date was this
provided?
NA Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
30/9/2001 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity Avita Medical Limited
ABN 28 058 466 523
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director Dalton Leslie Gooding
Date of last notice 30 June 2011
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Perth Investment Corporation – director &
beneficial shareholder
Moulyinning Nominees Pty Ltd – director &
beneficial shareholder
Date of change 30 October 2012
No. of securities held prior to change Indirect Perth Investment Corporation
2,014,288 shares
Indirect Moulyinning Nominees
1,048,573 shares
Class Ordinary Fully Paid Shares
Number acquired 291,667
Number disposed -
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$0.12 per share Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 30/9/2001
No. of securities held after change Indirect Perth Investment Corporation
2,014,288 shares
Indirect Moulyinning Nominees
1,340,240 shares
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan,
participation in buy-back
Off-Market – Placement as approved by
shareholders at 19 October 2012 shareholder
meeting
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change
Part 3 –
+Closed period
Were the interests in the securities or contracts detailed
above traded during a
+
closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
NA
If prior written clearance was provided, on what date was this
provided?
Yes via Shareholder notice of
meeting dated 17 May 2011 Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
30/9/2001 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity Avita Medical Limited
ABN 28 058 466 523
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director William Ford Dolphin
Date of last notice 5 October 2011
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
William & Alison Dolphin <The
Dolphin Family Super Fund>
Date of change 30 October 2012
No. of securities held prior to change Indirect - William & Alison Dolphin <The
Dolphin Family Super Fund>
1,519,047 ordinary shares
Direct
359,522 ordinary shares
4,882,500 unlisted options, expiring
14/11/2014, exercise price $0.14
1,000,000 unlisted options, expiring
30/11/2015 exercise price $0.14
1,660,000 unlisted options, expiring
30/11/2016 exercise price $0.14
1,500,000 unlisted options, expiring
30/11/2017 exercise price $0.14
750,000 unlisted options, expiring
30/11/2018 exercise price $0.14
Class Ordinary Shares Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 30/9/2001
Number acquired 125,000
Number disposed
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$0.12 per share
No. of securities held after change Indirect - William & Alison Dolphin <The
Dolphin Family Super Fund>
1,644,047 ordinary shares
Direct
359,522 ordinary shares
4,882,500 unlisted options, expiring
14/11/2014, exercise price $0.14
1,000,000 unlisted options, expiring
30/11/2015 exercise price $0.14
1,660,000 unlisted options, expiring
30/11/2016 exercise price $0.14
1,500,000 unlisted options, expiring
30/11/2017 exercise price $0.14
750,000 unlisted options, expiring
30/11/2018 exercise price $0.14
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan,
participation in buy-back
Off-Market – Placement as approved by
shareholders at 19 October 2012 shareholder
meeting
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
30/9/2001 Appendix 3Y Page 3